DPP4 and diabetes mellitus: Similarly to the study presented here, a previous post-hoc analysis compared the two doses of canagliflozin (100 mg and 300 mg) with the dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin (100 mg) in the attainment of diabetes-related QMs of glycemic control, BP, and body weight.